{"id":"https://openalex.org/W4396843564","doi":null,"title":"New therapeutic targets and drugs for cholestatic liver disease","display_name":"New therapeutic targets and drugs for cholestatic liver disease","publication_year":2019,"publication_date":"2019-02-01","ids":{"openalex":"https://openalex.org/W4396843564"},"language":"en","primary_location":{"id":"pmh:oai:doaj.org/article:b4ce9ab4fee040a09b9efc99356d4c3f","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/b4ce9ab4fee040a09b9efc99356d4c3f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Linchuang Gandanbing Zazhi, Vol 35, Iss 2, Pp 262-265 (2019)","raw_type":"article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["doaj"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5097927027","display_name":"GUO Mengmeng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"GUO Mengmeng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5097927027"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.41132577,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12460","display_name":"Pediatric Hepatobiliary Diseases and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cholestatic-liver-disease","display_name":"cholestatic liver disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/primary-biliary-cholangitis","display_name":"primary biliary cirrhosis","score":0.9959999918937683},{"id":"https://openalex.org/keywords/primary-sclerosing-cholangitis","display_name":"primary sclerosing cholangitis","score":1.0},{"id":"https://openalex.org/keywords/ursodeoxycholic-acid","display_name":"ursodeoxycholic acid","score":0.9440000057220459},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.777999997138977},{"id":"https://openalex.org/keywords/novel-therapies","display_name":"new drugs","score":0.5759999752044678},{"id":"https://openalex.org/keywords/immune-pathways","display_name":"immune pathways","score":0.6629999876022339},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.8320000171661377},{"id":"https://openalex.org/keywords/cholestasis","display_name":"cholestasis","score":0.6460000276565552}],"concepts":[{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5570091605186462},{"id":"https://openalex.org/C2777075537","wikidata":"https://www.wikidata.org/wiki/Q929737","display_name":"Liver disease","level":2,"score":0.5222288370132446},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41339111328125},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3216295540332794},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24300211668014526}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:doaj.org/article:b4ce9ab4fee040a09b9efc99356d4c3f","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/b4ce9ab4fee040a09b9efc99356d4c3f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Linchuang Gandanbing Zazhi, Vol 35, Iss 2, Pp 262-265 (2019)","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2888397144","https://openalex.org/W2572174115","https://openalex.org/W3172673257","https://openalex.org/W2567070990","https://openalex.org/W2565416332","https://openalex.org/W1965412899","https://openalex.org/W4396832785","https://openalex.org/W2972938582","https://openalex.org/W1980238898","https://openalex.org/W2003014492"],"abstract_inverted_index":{"Cholestatic":[0],"liver":[1,37,39,44,61,84],"disease":[2],"is":[3,28],"caused":[4],"by":[5],"the":[6,56,74,104,132],"damage":[7],"of":[8,20,76,110,118],"bile":[9,16,21,111],"duct":[10,17],"cells":[11],"and":[12,23,41,50,79,114,136,140],"hepatocytes":[13],"due":[14],"to":[15,36,91],"injury,":[18],"accumulation":[19],"acids,":[22],"persistent":[24],"inflammation.":[25],"If":[26],"it":[27],"not":[29],"treated":[30],"in":[31,63,107,121],"time,":[32],"cholestasis":[33],"can":[34,72],"lead":[35],"fibrosis,":[38],"cirrhosis,":[40],"even":[42],"end-stage":[43],"disease.":[45],"Primary":[46],"biliary":[47],"cholangitis":[48,53],"(PBC)":[49],"primary":[51],"sclerosing":[52],"(PSC)":[54],"are":[55,96],"two":[57],"most":[58],"common":[59],"cholestatic":[60],"diseases":[62],"adults,":[64],"with":[65],"unknown":[66],"causes.":[67],"Although":[68],"ursodeoxycholic":[69],"acid":[70,112],"(UDCA)":[71],"improve":[73],"prognosis":[75],"PBC":[77,139],"patients":[78,87],"prolong":[80],"survival":[81],"time":[82],"after":[83],"transplantation,":[85],"some":[86],"have":[88,127],"no":[89,98],"response":[90],"UDCA.":[92],"In":[93],"addition,":[94],"there":[95],"still":[97],"effective":[99],"pharmacotherapies":[100],"for":[101,138],"PSC.":[102,141],"With":[103],"research":[105],"advances":[106],"molecular":[108],"mechanism":[109],"regulation":[113],"a":[115],"deeper":[116],"understanding":[117],"immune":[119],"pathways":[120],"recent":[122],"years,":[123],"several":[124],"new":[125,133],"drugs":[126,137],"emerged.":[128],"This":[129],"article":[130],"introduces":[131],"therapeutic":[134],"targets":[135]},"counts_by_year":[],"updated_date":"2026-05-06T06:10:43.113611","created_date":"2024-05-12T00:00:00"}